Products for Research Use Only
RegisterLogin

SY-5609

CAT: 0931-T36038-07Size: 10 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0931-T36038-07Size:10 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
2417302-07-7
Target
Apoptosis, CDK
Related Pathways
Apoptosis, Cell Cycle/Checkpoint
Purity
>99.99%
Bioactivity
SY-5609 (CDK7-IN-3) is a selective non-covalent CDK7 inhibitor (Kd value is 0.07 nM), with weak inhibitory activity against CDK2, CDK9 and CDK12 with IC50 values ​​of 5.5, 1.9 and 1.7 μM, respectively, and has anti-tumor activity and inhibits cell apoptosis.
Smiles
C(F)(F)(F)C=1C(C=2C=3C(NC2)=C(P(C)(C)=O)C(C#N)=CC3)=NC(N[C@H]4CCC(C)(C)NC4)=NC1
Molecular Formula
C23H26F3N6OP
Molecular Weight
490.46
Shipping Conditions
Ice Packs
Storage Temperature
-20°C

Chemical Information

Sy-5609

CDK7 Inhibitor SY-5609 is an orally bioavailable, selective inhibitor of cyclin-dependent kinase 7 (CDK7), with potential antineoplastic activity. Upon oral administration, SY-5609 selectively targets, binds to and inhibits the activity of CDK7, thereby inhibiting CDK7-mediated signaling. Specifically, inhibition of CDK7 prevents phosphorylation of the carboxy-terminal domain (CTD) of RNA Polymerase II, thereby preventing transcription of important cancer-promoting genes. In addition, it prevents phosphorylation of the cell cycle kinases CDK1, 2, 4, and 6, thereby disrupting uncontrolled cell cycle progression. Altogether, this may induce apoptosis, cause cell cycle arrest, inhibit DNA damage repair and inhibit tumor cell proliferation in certain cancers that are dependent on CDK7-mediated transcriptional regulation and signaling. CDK7, a serine/threonine kinase, plays a role in controlling cell cycle progression, transcriptional regulation, and promotes the expression of key oncogenes such as c-Myc and beta-catenin, through the phosphorylation of RNA polymerase II.

CAS Number2417302-07-7
PubChem CID146662729
IUPAC Name7-dimethylphosphoryl-3-[2-[[(3S)-6,6-dimethylpiperidin-3-yl]amino]-5-(trifluoromethyl)pyrimidin-4-yl]-1H-indole-6-carbonitrile
Molecular FormulaC23H26F3N6OP
Molecular Weight490.5
XLogP2.7
Topological Polar Surface Area106
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count9
Rotatable Bond Count4
Heavy Atom Count34
Formal Charge0
Complexity838
SMILES
CC1(CC[C@@H](CN1)NC2=NC=C(C(=N2)C3=CNC4=C3C=CC(=C4P(=O)(C)C)C#N)C(F)(F)F)C
InChI
InChI=1S/C23H26F3N6OP/c1-22(2)8-7-14(10-30-22)31-21-29-12-17(23(24,25)26)18(32-21)16-11-28-19-15(16)6-5-13(9-27)20(19)34(3,4)33/h5-6,11-12,14,28,30H,7-8,10H2,1-4H3,(H,29,31,32)/t14-/m0/s1
InChIKey
JDJOUBVVSQDIRC-AWEZNQCLSA-N
Chemical Structure
2D Structure
2D structure of Sy-5609
CAS: 2417302-07-7
CID: 146662729
Formula: C23H26F3N6OP
MW: 490.5
Interactive 3D Structure
Loading 3D structure...
View on PubChemRaw 3D data
Computed Properties
PropertyValue
Molecular Weight490.5
XLogP32.7
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count9
Rotatable Bond Count4
Exact Mass490.18578096
Monoisotopic Mass490.18578096
Topological Polar Surface Area106 Ų
Heavy Atom Count34
Formal Charge0
Complexity838
Isotope Atom Count0
Defined Atom Stereocenter Count1
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently-Bonded Unit Count1
Compound Is CanonicalizedYes

Related Products

CatalogName
T31065-01CP-5609
T37859-01SY-640
T60429SY-LB-57
T60365SY-LB-35
T206454-01SY-21 NHS ester
T32935LUF-5608
T126905-01Compound STOCK1N-56096
T4101-01SC-560
T87319-01RGH-560
T16133-01MRK-560

Alternative Products

CatalogName
E1041-25mgSY-5609
A24279-5SY-5609 (CDK7-IN-3) 5mg
A24279-10SY-5609 (CDK7-IN-3) 10mg
A24279-1SY-5609 (CDK7-IN-3) 1mg
A24279-50SY-5609 (CDK7-IN-3) 50mg
MBS5780686CP-5609
HY-180355SY-5102
MBS133151SY-1365
MBS5785279SY-640

Popular Products